EVOLVE NEWS & EVENTS New research is first to show how key gut bacterium trains infant immune system Study published in cell reveals critical role of activated B. infantis EVC001 in using human milk to program immune cells early in life to control inflammation and autoimmune disease risk Read More JUNE 17, 2021 New study reports reductions in diaper rash and colic as well as improvement in sleep in infants following supplementation with the specific gut bacterium activated B. infantis EVC001 Researchers publishing today in the peer-reviewed science journal Beneficial Microbes reported that three common infant health issues associated with Newborn Gut Deficiency – diaper rash, colic and sleep problems – were substantially reduced or eliminated altogether within days of introducing a key beneficial gut bacterium that is missing in more than 90% of all babies in the U.S. Read More JUNE 8, 2021 Investors Continue to Support Breakthrough Research on Infant Gut Health Evolve's final round of funding will help further the brand's goal of resolving Newborn Gut Deficiency in the U.S Read More MAY 25, 2021 Evolve BioSystems, Inc. Announces the Use of Activated B. infantis EVC001 by International Consortium to Study the Prevention of Type 1 Diabetes in Children Study is led by the Institute for Diabetes Research at Helmholtz Zentrum München and conducted by the Global Platform for the Prevention of Autoimmune Diabetes Read More MARCH 11, 2021 New study reports activated B. infantis EVC001 improves health outcomes in preterm infants Study quantifies unprecedented reduction in enteric inflammation, diaper rash and antibiotic use via beneficial gut remodeling Read More FEBRUARY 16, 2021 Evolve BioSystems Announces Major Strategic Investment from Cargill and Manna Tree to Support Innovative Probiotic That Dramatically Improves Infant Gut Health Evolve’s innovative probiotic addresses widespread Newborn Gut Deficiency by restoring key bacteria in the infant gut microbiome Read More FEBRUARY 8, 2021 New study: Nine out of ten U.S. infants experience gut microbiome deficiency Largest study to date benchmarks widespread, underrecognized microbiome-linked risk to infant immune system development, antibiotic resistance, acute conditions such as colic and diaper rash Read More JANUARY 21, 2021 Genetic analysis of B. infantis strains reveal functional superiority of activated EVC001 in infants Unique mechanism of action of the probiotic bacteria B. infantis EVC001 allows for full utilization of human milk and maximizes benefit in the infant gut. Read More OCTOBER 27, 2020 OLDER CONTACT Evolve BioSystems mailing address: 2121 2nd St., Suite C108 Davis, CA 95618 info@evolvebiosystems.com GET STARTED Home About Science News Resources Careers NEWSLETTER Stay up to date with Evolve. Subscribe SUBSCRIBE © 2019 EVOLVE BIOSYSTEMS. ALL RIGHTS RESERVED. TERMS | PRIVACY POLICY